Mallinckrodt Hospital Products Inc. recalls Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
- Products
-
- Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL)
- Where it was sold
-
USA nationwide
Nationwide
- Units affected
- 8 vials involved in recall (16,479 vials distributed)
- About this recall
- Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1